Eli Lilly Positions on U.S. Legislation - MapLight

Eli Lilly Positions on U.S. Legislation

Eli Lilly Positions on U.S. Legislation - MapLight
Eli Lilly Positions on U.S. Legislation
Published Oct 23, 2020
255 pages — Published Oct 23, 2020
Price US$ 125.00  |  Buy this Report Now

About This Report

  
Abstract:

Eli Lilly Bill Positions
MapLight's report on Eli Lilly details Eli Lilly 's support for or opposition to bills in Congress. MapLight has recorded 61 bill positions taken by Eli Lilly since January 1, 2007. These bills relate to topics including Government Operations and Politics, Health, Legal Issues, Business and Commerce, Intellectual Property, and 49 other topics.
Support and opposition information is based on public documents found by MapLight, including congressional testimony, news reports, and company statements. These documents are included with the report.

Scope:
This report provides, for each of the 61 bills Eli Lilly has taken a position on, the following information:
* Bill name, number, and sponsor.
* Bill summary and status (i.e. whether the bill is in committee, has become law, etc.).
* Eli Lilly 's position (support or opposition).
* Date Eli Lilly 's position was taken and date it was recorded by MapLight.
* Source document for the support or opposition stance.

Source documents:
Source documents for Eli Lilly 's support or opposition stance are authored by:
* United States Senate Committee on Finance; 2nd Company letter to Senate on Tax Extenders (6 pages)
* Invest in America's Future; Company, Organization Letter to Congress on the R&D Tax Credit (7 pages)
* Multi Industry Opposition (2 pages)
* Chamber of Commerce (4 pages)
* Chamber of Commerce (4 pages)
* HR Multi Opposition (2 pages)
* Invest in America's Future; Company, Organization Letter to Congress on the R&D Tax Credit (7 pages)
* U.S. Chamber of Commerce; Multi-industry letter opposing S. 1504, the 'Notice Pleading Restoration Act of 2009' (4 pages)
* Business Roundtable; TAP Coalition America COMPETES Senate Letter (2 pages)
* And others.

Reasons to buy:
* Gauge future potential of Eli Lilly based on whether a bill they support or oppose advances or is defeated in Congress.
* Evaluate the political activity of Eli Lilly , including legislation of interest.
* Understand the reasoning behind Eli Lilly 's positions on legislation through content of source documents.
* Learn of other organizations that have taken the same position as Eli Lilly on a bill (other signers).
* Learn of legislation which affects the financial prospects of Eli Lilly .
* Learn whether bills Eli Lilly has supported or opposed have been enacted, defeated, or are still pending.

Topics of legislation:
The bills Eli Lilly has taken a position on cover the following topics: Business & Labor (38), Government Affairs (35), Legal Affairs (26), Health & Welfare (25), Budget & Economy (20), Science, Technology, Communications, and Infrastructure (18), Culture and Social Issues (13), Defense, National Security and Foreign Policy (8), Natural Resources (7), Education (3). The report is 255 pages long, including 62 source documents.

  
Source:
Document ID
8941506000
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MapLight—Company positions on U.S. legislation reports detail support for and opposition to bills in the U.S. Congress, for the most politically active companies, unions, associations, and interest groups. The reports are based on public documents, including company statements, news reports, and congressional testimony. These documents are included with the reports.

About the Author


Cite this Report

  
MLA:
MapLight. "Eli Lilly Positions on U.S. Legislation" Oct 23, 2020. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/MapLight/Eli-Lilly-Positions-on-U-S-Legislation-2154-80>
  
APA:
MapLight. (2020). Eli Lilly Positions on U.S. Legislation Oct 23, 2020. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/MapLight/Eli-Lilly-Positions-on-U-S-Legislation-2154-80>
  
US$ 125.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Company Profiles from one place.